ANDA 87195, held by Valeant Pharmaceuticals International. Atropine Sulfate; Diphenoxylate Hydrochloride.
As of Nov 22, 2026, ANDA 87195 (Diphenoxylate Hydrochloride and Atropine Sulfate), held by Valeant Pharmaceuticals International, was first approved by FDA on Mar 5, 1997, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 5, 1997 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diphenoxylate Hydrochloride and Atropine Sulfate0.025MG;2.5MG · tablet;oral | Atropine Sulfate; Diphenoxylate Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters